Article Versions Notes

Fagnani L, Nazzicone L, Bellio P, Franceschini N, Tondi D, Verri A, Petricca S, Iorio R, Amicosante G, Perilli M, et al. Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators. Pharmaceuticals. 2022; 15(6):714. https://doi.org/10.3390/ph15060714

Fagnani, Lorenza, Lisaurora Nazzicone, Pierangelo Bellio, Nicola Franceschini, Donatella Tondi, Andrea Verri, Sabrina Petricca, Roberto Iorio, Gianfranco Amicosante, Mariagrazia Perilli, and et al. 2022. "Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators" Pharmaceuticals 15, no. 6: 714. https://doi.org/10.3390/ph15060714

Fagnani, L., Nazzicone, L., Bellio, P., Franceschini, N., Tondi, D., Verri, A., Petricca, S., Iorio, R., Amicosante, G., Perilli, M., & Celenza, G. (2022). Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators. Pharmaceuticals, 15(6), 714. https://doi.org/10.3390/ph15060714